AMR Collaboration Leverage PharmaLex's AMR partnerships with BIOASTER and with MAP and Cpharm networks to position PhlexTMF as the automation ready platform for antimicrobial resistance programs, targeting biotech and pharma clients engaged in AMR research. Propose joint go to market with BIOASTER and the MAP and Cpharm networks to accelerate AMR project wins.

Geographic Expansion Ongoing growth in Australia, New Zealand and Italy expands addressable markets for TMF and related services. Leverage AmerisourceBergen and Cencora channels to reach global pharma and CRO clients, offering PhlexTMF together with pharmacovigilance services as a bundled solution in these regions.

TMF Technology Edge PhlexTMF offers advanced best practices, automation, and a user focused design that support faster, compliant TMF deployments. Target large CROs and mid sized pharma seeking scalable data workflows with Databricks and SAS and cloud infrastructure.

Strategic Backing Backed by the PharmaLex Group and the Cencora family, the company has access to capital and global reach. Pursue enterprise outsourcing deals and global trial programs that require integrated TMF automation with related services.

Integrated Service Suite Recent mergers with Cpharm and MAP and the AMR hub create a one stop solution for pharmacovigilance, medical information, and TMF automation. Pitch bundled offerings for life sciences firms running cross border trials and regulatory submissions.